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Abstract
Cultured IFN-γ ELISPOT assays are primarily a measure of central memory T cell (Tcm) re-
sponses with humans; however, this important subset of lymphocytes is poorly character-
ized in cattle. Vaccine-elicited cultured IFN-γ ELISPOT responses correlate with protection
against bovine tuberculosis in cattle. However, whether this assay measures cattle Tcm re-
sponses or not is uncertain. The objective of the present study was to characterize the rela-
tive contribution of Tcm (CCR7+, CD62Lhi, CD45RO+), T effector memory (Tem, defined as:
CCR7-, CD62Llow/int, CD45RO+), and T effector cells (CCR7-, CD62L-/low, CD45RO-), in the
immune response toMycobacterium bovis. Peripheral blood mononuclear cells (PBMC)
from infected cattle were stimulated with a cocktail ofM. bovis purified protein derivative,
rTb10.4 and rAg85A for 13 days with periodic addition of fresh media and rIL-2. On day 13,
cultured PBMC were re-stimulated with medium alone, rESAT-6:CFP10 or PPDb with fresh
autologous adherent cells for antigen presentation. Cultured cells (13 days) or fresh
PBMCs (ex vivo response) from the same calves were analyzed for IFN-γ production, prolif-
eration, and CD4, CD45RO, CD62L, CD44, and CCR7 expression via flow cytometry after
overnight stimulation. In response to mycobacterial antigens, ~75% of CD4+ IFN-γ+ cells in
long-term cultures expressed a Tcm phenotype while less than 10% of the ex vivo response
consisted of Tcm cells. Upon re-exposure to antigen, long-term cultured cells were highly
proliferative, a distinctive characteristic of Tcm, and the predominant phenotype within the
long-term cultures switched from Tcm to Tem. These findings suggest that proliferative re-
sponses of Tcm cells to some extent occurs simultaneously with reversion to effector phe-
notypes (mostly Tem). The present study characterizes Tcm cells of cattle and their
participation in the response toM. bovis infection.
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Introduction
Bovine tuberculosis (bTB) is a chronic bacterial disease of animals that may also infect humans.
Mycobacterium bovis, the main agent causing bTB, is a member of theMycobacterium tubercu-
losis complex, which also comprises:M. tuberculosis (M. tb),M. canettii,M. africanum,M. pin-
nipedii,M.microti,M. caprae andM.mungi [1, 2]. This genetically related group of bacteria
causes TB with comparable pathology in a wide variety of hosts [3, 4]. Great strides have been
made over the past century in the control of bTB in cattle and to limit the risk to humans (e.g.,
pasteurization of milk for dairy products); however, the disease persists as a significant socio-
economic hardship for livestock farmers with estimates of>50 million cattle infected world-
wide, costing $3 billion annually. The WHO (World Health Organization), in conjunction
with FAO (Food and Agriculture Organization of the United Nations) and OIE (Office Inter-
national des Épizooties), recently classified bTB as a neglected zoonosis.
An essential component of the immune response to TB in humans, cattle and mice is the
production of IFN-γ by T helper 1 (Th1) CD4 T cells [5–10]. Immune deficiencies affecting
CD4 T cells (e.g., HIV infection) and IL-12/IFN-γ /STAT1 signaling pathways result in more
severe disease upon TB infection in humans [11,12]. Given the importance of Th1 cells in the
immune response to TB, it is not surprising that IFN-γ release assays (IGRA) and delayed type
hypersensitivity (i.e., skin test) responses are useful correlates of infection (reviewed by Schiller
et al. [13] for cattle and Walzl et al. [14] for humans). Widely utilized in IGRAs, early secretory
antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) are potent inducers of
Th-1 cytokines [15]. ESAT-6 and CFP-10 are co-secreted proteins encoded by the RD-1 region
of the genome ofM. tb complex mycobacteria. Such genes are absent in allM. bovis bacillus
Calmette Guerin (BCG) strains and most other non-tuberculous mycobacteria species [16–19].
Diagnostic IGRA’s are measures of ‘ex vivo’ immune responses relying on rapid production of
IFN-γ in response to mycobacterial antigen stimulation in short-term (16–24 h) whole blood
or peripheral blood mononuclear cell (PBMC) cultures. Ex vivo assays for use in bTB diagnosis
are generally considered a measure of T cell effector responses and are frequently used to mea-
sure immune responses to bTB vaccines prior to and after challenge with virulentM. bovis
[9,20]. While most protective bTB vaccines elicit ex vivo IFN-γ responses, not all vaccines that
induce this response provide protection [21]. Additionally, levels of IFN-γ elicited by vaccina-
tion do not necessarily correlate with the level of protection afforded by the vaccine [22]. Thus,
the identification of correlates of protection is needed to prioritize vaccine candidates for evalu-
ation in costly BL-3 vaccination/challenge efficacy trials.
Recent vaccine efficacy studies in cattle have demonstrated that long-term cultured IFN-γ
ELISPOT (so called, cultured IFN-γ ELISPOT) responses are positive predictors of vaccine effi-
cacy [23–25] and duration of immunity [26]. Protection provided by vaccination is partial and
protected animals have reduced mycobacterial burden and associated pathology following ex-
perimental infection. In this assay, PBMCs are stimulated with antigens for 10–13 days and
maintained by fresh media exchange and exogenous IL-2. After this initial culture period, cells
are re-stimulated for an additional 20 h in the presence of autologous antigen presenting cells
(APC) in anti-IFN-γ coated ELISPOT plates. Studies with samples from humans have demon-
strated that cultured ELISPOT responses are primarily a measure of T cell memory (Tcm) cells
[27–29].
Sallusto et al. [30] identified two functionally distinct subsets of memory T cells (i.e.,
CD45RA-/CD45RO+) in mice and humans based on expression of the lymphoid homing recep-
tors CD62L and CCR7. These two subsets are: (1) Tcm cells which express CD62L and CCR7
and are preferentially located in lymphoid tissues and (2) effector memory T (Tem) cells which
lack CD62L and CCR7 expression and are preferentially located in peripheral tissues or remain
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blood associated, either circulating or contained within splenic red pulp or hepatic sinusoids
[31]. Tem cells show immediate effector functions, maintaining preformed cytotoxic granules
for rapid cytolysis of infected host cells [32]. Tcm cells show elevated proliferation and IL-2 pro-
duction capabilities, being able to generate Tem and effector cells [33] whereas Tem cells under-
go relatively little proliferation and secrete minimal IL-2 upon restimulation [28,31,33]. While
Tcm and Tem have different roles in the immune response, both subsets are thought to be im-
portant for protection against pathogens. Still, due to the high proliferative capacity and long
life span of Tcm, the eliciting of Tcm is believed to provide long-term protection.
The cultured ELISPOT assay measures memory responses, primarily Tcm in humans [27–29].
Godkin et al. [27] tracked hepatitis C virus HLA-DR11-restricted epitopes in the course of the
long-term culture, demonstrating that cultured ELISPOT IFN-γ production was due to long-
lived CD4+ Tcm expressing CCR7. The fundamental role of CCR7+ CD4 cells was also reported
by Todryk et al. [34]; these authors assessed the effect of depletion of CCR7 expressing cells on ex
vivo or cultured ELISPOT responses to either influenza antigenic peptides orM. tb purified pro-
tein derivative (PPD). The depletion of CCR7+ cells dramatically reduced cultured ELISPOT re-
sponses, yet had only a minimal effect on ex vivo responses. Supportive of the idea that the
cultured ELISPOT response is a measure of Tcm responses, several studies have shown the associ-
ation of responses measured by this assay with protection against malaria, suppression of viral re-
crudescence in hepatitis B virus carriers, low viremia in human immunodeficiency virus (HIV)
infection, and favorable outcomes in human TB [28,35–38].
While responses measured by cultured IFN-γ ELISPOT following vaccination correlate to
protection with bTB; the phenotype of the responding cells within the long-term cultures has
not been determined for cattle in response to neither vaccination nor infection. A better under-
standing of the cattle immune system may enable the development of improved vaccine strate-
gies and consequently, greater protection against this zoonotic disease of cattle. In the present




All studies were approved by the National Animal Disease Center Animal Care and Use (Proto-
col #’s ACUP-2508 and ACUP-2688) / Institutional Biosafety (Permit #’s IBC-0285A and IBC-
0004RA) committees and performed under appropriate project licenses within the conditions of
the Animal Welfare Act originally signed into law in 1966 and in accordance with the most re-
cent amendments. All animals were housed in appropriate biological containment facilities at
the National Animal Disease Center. Animals did not develop clinical signs of bTB (such as:
cough, dyspnea, anorexia and weight loss); however, one animal (from the non-infected control
group) was euthanized by intravenous administration of sodium pentobarbital due to an
umbilical infection.
Mycobacterium bovis aerosol challenge procedures
Two field strains ofM. bovis were used for challenge inoculum: 95–1315 (Michigan white-
tailed deer isolate) and 10–7428 (Colorado dairy isolate). Low passage ( 3) cultures of both
strains were prepared using standard techniques in Middlebrook 7H9 liquid media (Becton
Dickinson, Franklin Lakes, NJ) supplemented with 10% oleic acid-albumin-dextrose complex
(OADC) plus 0.05% Tween 80 (Sigma, St. Louis, Missouri). Holstein steers (~ 6 months of age)
were obtained from a bTB-free herd in Sioux Center, IA and housed in a biosafety level-3
(BSL-3) facility at NADC in separate rooms based upon treatment group. For the first
Bovine Central Memory T Cells
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experiment, treatment groups consisted of non-infected steers (n = 7) and animals receiving
104 colony-forming units (cfu) ofM. bovis 95–1315 (n = 8), orM. bovis 10–7428 (n = 8). For
the second study, a single group of steers (n = 8) received 104 cfuM. bovis 10–7428. For both
studies,M. bovis challenge inoculum was delivered to restrained calves (~9 months of age) by
aerosol as described by Palmer et al. [39]. Briefly, inoculum was nebulized into a mask (Trudell
Medical International, London, ON, Canada) covering the nostrils and mouth, allowing regular
breathing and delivery of the mycobacteria to the lungs via the nostrils. The process continued
until the inoculum, a 1 ml PBS wash of the inoculum tube, and an additional 2 ml PBS were de-
livered—a process taking ~10 min. Strict biosafety protocols were followed to protect personnel
from exposure toM. bovis throughout the study, including BSL-3 containment upon initiation
ofM. bovis challenge in animal rooms and standard laboratory practices for handlingM. bovis
cultures and samples fromM. bovis-infected animals.
Mycobacterial isolation and assessment of lesions
All calves were euthanized ~4 months after challenge by intravenous administration of sodium
pentobarbital. Tissues were examined for gross lesions and processed for microscopic analysis
and isolation ofM. bovis. Tissues collected included: lung; liver; mandibular, parotid, medial ret-
ropharyngeal, mediastinal, tracheobronchial, hepatic, and mesenteric lymph nodes. Lymph
nodes were sectioned at 0.5 cm intervals and examined. Each lung lobe was sectioned at 0.5–1.0
cm intervals and examined separately. Lungs and lymph nodes (mediastinal and tracheobron-
chial) were evaluated using a semi-quantitative gross pathology scoring system adapted from
Vordermeier et al.[9]. Tissues collected for microscopic analysis were fixed by immersion in
10% neutral buffered formalin. For microscopic examination, formalin-fixed tissues were pro-
cessed by standard paraffin-embedment techniques, cut in 5 μm sections and stained with he-
matoxylin and eosin. Adjacent sections from samples containing caseonecrotic granulomata
suggestive of bTB were stained by the Ziehl-Neelsen technique for identification of acid-fast
bacteria. Microscopic tuberculous lesions were staged (I-IV) based on a scoring system devel-
oped byWangoo et al. [40].
Ex vivo and long-term cell culture
PBMC were isolated from buffy coat fractions of blood collected in 2 × acid-citrate-dextrose so-
lution. Complete RPMI medium for PBMC cell culture was RPMI 1640 (GIBCO, Grand Is-
land) supplemented with 2 mM L-glutamine, 25 mMHEPES buffer, 100 U/ml penicillin, 0.1
mg/ml streptomycin, 1% non-essential amino acids (Sigma, St. Louis, MO), 2% essential amino
acids (Sigma), 1% sodium pyruvate (Sigma), 50 mM 2-mercaptoethanol (Sigma), and 10%
(v/v) fetal bovine sera (FBS). Long-term cell cultures were generated by stimulating 2 × 106/ml
PBMC with a cocktail ofM. bovis PPD (PPDb, 5 μg/ml, Prionics Ag, Sclieren, Switzerland)
rAg85A (1 μg/ml, LIONEX Diagnostics and Therapeutics GmbH, Braunschweig, Germany),
rTB10.4 (1 μg/ml, LIONEX Diagnostics and Therapeutics GmbH), and rESAT-6/CFP-10
(1 μg/ml, kind gift from Chris Minion, Iowa State University) in complete RPMI medium.
Cells were cultured (2 × 106 cells/well, 1 ml/well) in 24 well flat-bottom microtiter plates
(Nunc, Thermo Fisher, Waltham, MA). Media containing human rIL-2 (Sigma, 10 U/ml) was
used to replace media from the PBMC cultures at days 3 and 7. Fresh media without IL-2 was
used at days 10 and 12. For ELISPOT assays, at day 13, cultured cells were added (2 × 104 of
cultured PBMC/well) to anti-bovine IFN-γ capture-mAb (Serotec, Oxford, UK) coated 96-well
ELISPOT plates (Millipore, Watford, UK) and incubated in the presence of autologous APCs
and either PPDb (5 μg/ml), rESAT-6:CFP10 (1 μg/ml), pokeweed mitogen (PWM, Sigma)
(1μg/ml) or medium alone. Autologous APCs were isolated by adherence incubating 1 × 105
Bovine Central Memory T Cells
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freshly isolated PBMC in complete medium at 39°C/5% CO2 for 90 min in ELISPOT plates.
Non-adherent cells were discarded and the adherent cells (APCs) washed four times with
warm RPMI 1640 media. Fresh complete media containing antigen and long-term cultured
cells were then incubated 20h at 39°C/5% CO2. For flow cytometric analysis, cultured cells
were added (2 × 104 of cultured PBMC/well) to round-bottom well plates and incubated in the
presence of APCs and either PPDb (5 μg/ml), rESAT-6:CFP10 (1 μg/ml), PWM (1 μg/ml) or
medium alone. Autologous APCs were prepared as described for the ELISPOT assay. Fresh
complete media containing antigen and long-term cultured cells were then incubated 16 h at
39°C/5% CO2 with Brefeldin A (Sigma, 10 μg/ml) added at 4 h of culture.
IFN-γ ELISPOT
The IFN-γ ELISPOT assay was performed as described by Vordermeier et al. [41] andWhelan
et al., [25]. Briefly, polyvinyldifluoride 96-well ELISPOT plates (Millipore) were coated at 4°C
overnight with an anti-bovine IFN-γ capture mAb (Serotec), followed by a blocking step (10%
fetal bovine serum (FBS) in RPMI 1640 media, for 2 h at 39°C/5% CO2). Autologous APCs
were isolated by adherence on coated and blocked ELISPOT plates. Long-term cultured cells
(2 × 104 of cultured PBMC/well) were added to ELISPOT plates (Millipore, Watford, UK) and
incubated with either PPDb (5 μg/ml), rESAT-6:CFP10 (1 μg/ml), PWM (1 μg/ml) or medium
alone for 20 h at 39°C/5% CO2. Spot forming cells (SFC) were detected following the Vectastain
ABC-AP Kit (Vector Laboratories, Burlingame, CA) standard procedures.
Flow Cytometry
Following the appropriate culture duration, cells were pooled from individual animals accord-
ing to in vitro treatments (i.e., stimulation). Cells were stained as described by Maue et al. [42],
with the primary antibodies and appropriate secondary antibodies listed on the Table 1. CD4 T
cells were analyzed as a separate panel, while CD8 and γδ T cells staining was performed to-
gether to enable the analysis of CD8 expressing γδ T cells. Intracellular staining was performed
following BD Perm/Wash instructions (BD Biosciences, San Jose, CA).
For cell-trace labeling, cells were labeled with CellTrace Violet (Invitrogen, Carlsbad, CA)
following kit instructions. Briefly, either freshly isolated or long-term cells (cultured for 13
days) were resuspended at 1 × 107 cells in PBS containing 10 μM/ml of the cellTrace dye with
immediate vortexing to ensure rapid homogenous staining of cells. Staining was performed at
20°C and cell were incubated for 5 min. Cells were washed three times with PBS containing
10% FBS and cultured for additional six days in the presence of APCs and antigens in round-
bottom 96-well plates before cell staining with primary and secondary antibodies. For the long-
Table 1. Primary and secondarymonoclonal antibodies and proliferation staining reagents.
Reagent or antibody Specificity, Source Secondary antibodies, Source
ILA11 Bovine CD4, Washington State University Alexa-fluor 350, Life Technologies
ILA116 Bovine CD45RO, Washington State University FITC, SouthernBiotech or Allophycocyanin-Cy7, Life Technologies
7D12 Human CCR7, BD Pharmingen Allophycocyanin, SouthernBiotech
BAT31A Bovine CD44, Washington State University PE-Cy7, SouthernBiotech or Pacific blue, Life Technologies
BAQ92A Bovine CD62L, Washington State University Percp, SouthernBiotech
MCA1783-PE Bovine IFN-γ, AbD Serotec Not applicable
GB21A Bovine TCR1 δ chain, Washington State University PE-Cy7, SouthernBiotech
BAQ111A Bovine CD8, Washington State University PE, SouthernBiotech
CellTrace Violet Not applicable, Life Technologies Not applicable
doi:10.1371/journal.pone.0122571.t001
Bovine Central Memory T Cells
PLOS ONE | DOI:10.1371/journal.pone.0122571 April 16, 2015 5 / 20
term cultured cells the culture length was 19 days. Flow cytometric analysis was performed
with a BD LSR flow cytometer (BD Biosciences). Data were analyzed using FlowJo (Tree Star
Inc., San Carlos, CA).
Statistical analysis
Data were analyzed using Analysis of Variance followed by Tukey’s or Šídák’s multiple compari-
sons test or Student’s t test using GraphPAD Prism 6.0 (GraphPAD Software Inc., La Jolla, CA).
Results
AerosolM. bovis infection of cattle elicits long-term cultured IFN-γ
ELISPOT responses
Aerosol inoculation to cattle withM. bovis 95–1315 orM. bovis 10–7428 resulted in a similar
distribution and severity of gross and microscopic tuberculous lesions as well as mycobacterial
colonization, primarily affecting the lungs and lung-associated lymph nodes [43]. Specific cell-
mediated and antibody responses, including kinetics of the response as well as antigen recogni-
tion profiles, were also comparable between the two treatment groups [43,44].
With bTB vaccine efficacy studies, long-term cultured (i.e., 14 days) IFN-γ ELISPOT re-
sponses to vaccination (i.e., BCG,M. bovis ΔRD1, and viral-vectored Ag85) negatively correlates
with mycobacterial burden and TB-associated pathology and positively correlates with vaccine-
induced protection [23–25]. As with vaccination,M. bovis infection also elicited long-term cul-
tured IFN-γ ELISPOT responses in cattle (Fig 1). Three weeks after infection, long-term cul-
tured IFN-γ ELISPOT responses by PBMCs from infected cattle to rESAT-6:CFP10 and PPDb
exceeded (P< 0.05) respective responses by PBMCs from non-infected calves (Fig 1A). Similar
results were detected with ex vivo (i.e., short-term) responses (Fig 1B). Also, Tcm and ex vivo re-
sponses did not differ (P> 0.05) betweenM. bovis 95-1315- and 10-7428-infected groups
(S1 Fig). The weak response detected to PPDb by non-infected cattle in both ex vivo and long-
term cultures was likely due to prior exposure to non-tuberculous mycobacteria (NTM, a com-
mon occurrence in US dairy cattle) as pre-infection whole blood (18 h stimulation) IFN-γ re-
sponses toM. avium PPD (PPDa) exceeded (P< 0.05) respective responses to PPDb (S2 Fig).
Using intracellular cytokine staining, IFN-γ responses to PPDb and to rESAT-6:CFP10 were
also detected in long-term PBMC cultures at 3, 6, 8, and 12 weeks after aerosol infection
(Fig 1C). Responses increased (P< 0.05) from 3 and 6 to 12 weeks after infection. These find-
ings demonstrate that infection of cattle with virulentM. bovis elicits long-term cultured IFN-γ
ELISPOT responses, which are considered a surrogate of Tcm responses in humans [34,38,45].
Analysis of IFN-γ production in long-term cultures reveals a dominant
contribution by Tcm
The expression of CD45RO, CD4, CCR7 and intracellular expression of IFN-γ by PBMC cells
was evaluated following long-term or ex vivo culture (Fig 2). CD4 T cells producing IFN-γ fol-
lowing long-term culture predominantly co-expressed CD45RO and CCR7 surface antigens
(Fig 3), consistent with the Tcm phenotype described for humans and mice (S3 Fig) [26],[46].
The phenotype of cells responding to PPDb (CD4+ IFN-γ+) was compared under ex vivo versus
long-term culture conditions (Fig 3A and S4A Fig). The predominant cell phenotype respond-
ing to antigenic stimulation in long-term cultures was that of Tcm cells, whereas few Tcm were
present under ex vivo conditions (P< 0.01, % Tcm in long-term versus ex vivo cultures). In
contrast, effector cells contributed to ex vivo IFN-γ production, but only minimally to the long-
term culture response (P< 0.05). Tem cells contributed to IFN-γ production in both ex vivo
Bovine Central Memory T Cells
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Fig 1. Long-term cultured and ex vivo IFN- γ responses by cattle afterM. bovis aerosol challenge.
Cultured ELISPOT analysis was performed ~3 weeks after challenge with virulentM. bovis. Long-term
cultured cells were generated by stimulating PBMC with a cocktail of rAg85A (1 μg/ml), rTB10.4 (1 μg/ml),
and rESAT-6:CFP10 (1 μg/ml) antigens as well as PPDb (5 μg/ml) for 13 days followed by transfer to
ELISPOT plates with APCs and addition of either rESAT-6:CFP10, PPDb or medium alone. For the ex vivo
Bovine Central Memory T Cells
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(~50%) and long-term cultures (~25%). The respective overall effector/memory CD4 T cells
(i.e. CD4+ IFN-γ+/- cells) proportions under both long- and short-term conditions are shown
in S4B Fig The relative contribution of Tcm, Tem and effector CD4+ T cells in the response to
PPDb (Fig 3B) and to rESAT-6:CFP10 (Fig 3C) remained the same over the course of infection
(i.e., at 6, 8, and 12 weeks after challenge). In general a greater number of responding cells
(IFN-γ+) were observed in the long-term cultured assay as compared to the ex vivo assay
(Fig 3), perhaps due to the greater percentage of CD4 cells within long-term cultures (S5 Fig).
Tcm cells highly expressed (P< 0.05) CD62L and CD44 in response to either rESAT-6:
CFP10 or PPDb stimulation (Fig 4). Expression of CD62L was intermediate with Tem and low
response, freshly isolated PBMCs were stimulated with rESAT-6:CFP10, PPDb or medium alone for 16h.
Medium control responses were subtracted from antigen-stimulated responses and results are presented as
mean spot forming cells (SFC)/million cells (± SEM, n = 8) for (A) long-term culture or (B) ex vivo conditions.
(C) The kinetics of the response is shown as the percent of CD4+ cells producing IFN-γ in long-term cultures
at 3, 6, 8, and 12 weeks post infection (WPI n = 6). Two-way ANOVA (Šídák’s multiple comparison post-test).
doi:10.1371/journal.pone.0122571.g001
Fig 2. Representative gating strategy for evaluation of CD45RO and CCR7 expression on CD4 T cells producing IFN-γ. Approximately 8 weeks after
aerosol challenge withM. bovis, long-term cultures were generated by stimulating PBMCwith a cocktail of rAg85A (1 μg/ml), rTB10.4 (1 μg/ml) and rESAT-6:
CFP10 (1 μg/ml) as well as PPDb (5 μg/ml) for 13 days followed by transfer of cells to ELISPOT plates with APCs and restimulation with PPDb. Gating
hierarchy (gating sequence as depicted by the arrows): (A) Single cells (within the oblong gate), (B) Lymphocytes (within the polygon gate), (C) CD4+ cells,
(D) CD4+ cells producing IFN-γ, and (E) CD45RO and CCR7 expression for determination of effector/memory phenotypes.
doi:10.1371/journal.pone.0122571.g002
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to non-existent with effector cells (Fig 4A). CD44 expression was low in both Tem and effector
cells (Fig 4B).
Tcm cells possess high proliferative capability
Human CD4 memory T cells, predominantly those exhibiting Tcm phenotype, proliferate in
response to cytokine and antigenic stimulations, differentiating into Tem or effector T cells in
vitro [30,47]. To assess the proliferative capacity of bovine Tcm cells following long-term cul-
ture, cells were harvested at day 13 and stained with CellTrace Violet. CellTrace Violet stained
cells were re-stimulated with rESAT-6:CFP10 or PPDb for additional six days, without IL-2
(S5 Fig). For comparative purposes, freshly isolated PBMC were isolated and stained with Cell-
Trace Violet and cultured for six days (short-term culture). Cells proliferated in response to an-
tigenic stimulation under both long- and short-term conditions (Table 2). CD4 T cells were the
most proliferative fraction (P< 0.05), followed by γδ, CD8 T cells, and CD8 expressing γδ T
cells. In response to rESAT-6:CFP10 stimulation, the number of CD4 T cells proliferating in
Fig 3. Frequencies of Tcm, Tem and effector cells producing IFN-γ in response to mycobacterial antigens in long-term and ex vivo assays.
Peripheral blood mononuclear cells were isolated from calves ~ 8 weeks after challenge with virulentM. bovis. Cells were stimulated with a cocktail of
rAg85A (1 μg/ml), rTB10.4 (1 μg/ml), and rESAT-6:CFP10 (1 μg/ml) as well as PPDb (5 μg/ml) for 13 days followed by transfer to 96 well round bottom plates
with APCs and addition of media alone, PPDb or rESAT-6:CFP10 for an additional 16h. For ex vivo culture, PBMC were stimulated with media alone, PPDb
or rESAT-6:CFP10 for 16 h. (A) Relative contribution of Tcm, Tem, and T effector cells to IFN-γ production in response to PPDb by long-term (i.e., 14-day)
(left) and ex vivo (i.e., 16 h) (right) cultures, 8 weeks afterM. bovis challenge. Data are presented in percentages (pies) and as mean (± SEM) number of cells
producing IFN-γ / 104 cells (histograms) (n = 16). Relative contribution of Tcm, Tem and T effector cells to IFN-γ production in response to PPDb (B) or to
rESAT-6:CFP10 (C) in long-term cultures at three, six, eight or 12 weeks post-infection (WPI, n = 6). Tcm, Tem and effector cell phenotypes were as defined
in Fig 2 and S3 Fig Tcm and Effector T cell contribution to IFN-γ production differs (*P < 0.05; **P < 0.01, paired Student's t-tests) between short- and long-
term cultures.
doi:10.1371/journal.pone.0122571.g003
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long-term cultures exceeded (P< 0.05) that of short-term cultures. Similarly, the CellTrace Vi-
olet mean fluorescence intensity (MFI) was significantly lower (P = 0.003), indicating greater
cell proliferation in rESAT-6:CFP10-stimulated CD4 T cells in long- vs short-term cultures
(Fig 5 and Fig 6). Greater percentages of CD4 T cells (P< 0.05) proliferated under long-term
culture in response to either rESAT-6:CFP10 (Fig 6A) or PPDb (Fig 6B). These findings dem-
onstrate that bovine Tcm cells are highly proliferative in response to repeated stimulation with
recall antigen.
Given the robust participation of CD4 T cells in the long-term proliferative response and
the fact that Tcm cells are believed to generate effector cells, the phenotype of these cells (i.e.,
Fig 4. CD62L and CD44 expression by Tcm, Tem and effector CD4+ cells in long-term (14 day)
cultures. Analysis of long-term cultured PBMCs was performed ~ 8 weeks after aerosol challenge with
virulentM. bovis. Cells were stimulated with a cocktail of rAg85A (1 μg/ml), rTB10.4 (1 μg/ml), and rESAT-6:
CFP10 (1 μg/ml), as well as PPDb (5 μg/ml) for 13 days followed by transfer to 96 well round bottom plates
with APCs and addition of PPDb or rESAT-6:CFP10. Data are presented as mean fluorescence intensity
(MFI, y-axis, ± SEM) of CD62L or CD44 by CD4+ cells of the various effector / memory subsets (x-axis). (A)
CD62L expression by Tcm, Tem and effector cells in response to PPDb and rESAT-6:CFP10. (B) CD44
expression on Tcm, Tem and effector cells in response to PPDb and rESAT-6:CFP10. Tcm, Tem and effector
cell phenotypes were as defined in Fig 2 and S3 Fig Paired Student's t-tests (n = 8).
doi:10.1371/journal.pone.0122571.g004
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14-day cultured cells re-stimulated with antigen for an additional 6 days) was further assessed.
Again, PBMCs cultured under short-term culture conditions (6 days only) were used for com-
parison (Fig 6). The distribution of CD4 T cells into Tcm and effector subsets was different be-
tween short- and long-term conditions following stimulation with rESAT-6:CFP10 (Fig 6C) or
PPDb (Fig 6D). Greater (P< 0.05) numbers of Tcm cells were present in long-term (13 + 6
days) versus short-term (6 days) cultures; while more effector cells were present (P< 0.05) in
short—versus long-term cultures. The numbers of Tem and naïve cells were similar between
the two conditions. Tem cells were the main population in both cultures, whereas few naïve
cells persisted under either culture condition (Fig 6C and 6D). These findings indicate that
highly proliferative Tcm cells partially revert to effector (predominately Tem) phenotypes
upon additional exposure to antigen for 6 days (Fig 6C and 6D as compared to Fig 3).
Table 2. Lymphocyte subset proliferative responses ofM. bovis-infected cattle under short or long-term culture condition.
Culture Stimulation Mean cell number (± SEM) by cell subset (50,000 cells)
Ungated CD4+ CD8+ γδ TCR+ γδ TCR+ CD8+
Long-term culture rESAT-6:CFP-10 10,937 (±1476) 8,915 (±1,231) * 113 (±28) * 996 (±382) 51 (±9)
Short-term culture rESAT-6:CFP-10 7,407 (±975) 4,076 (±567) 468 (±197) 942 (±17) 141 (±27)
Long-term culture M. bovis PPD 15,061(±2187) 6,107 (±1343) 159 (±45) * 1354 (±68) 64 (±19)
Short-term culture M. bovis PPD 13,146 (±2835) 4,841 (±1742) 496 (±12) 1612 (±427) 89 (±20)
Long-term cells consist of PBMC from M. bovis-infected cattle cultured in the presence of rAg85A, rTB10.4, rESAT-6:CFP10 and PPDb for 13 days.
Subsequently, cells were stained with CellTrace violet dye and re-stimulated with either, PPDb, rESAT-6:CFP10 or medium in the presence of APCs for
an additional six days. Short-term cells consist of CellTrace Violet-stained PBMC from M. bovis-infected cattle (n = 4) cultured for six days in the presence
of either PPDb, rESAT-6:CFP10 or medium in the presence of APCs. Data are presented as the mean (±SEM) number of cells that had proliferated per
50,000 cells under short-term or long-term culture in response to antigen (PPDb or rESAT-6:CFP10) minus the response to media alone. *Responses
under long-term culture differ (P < 0.05,two-way ANOVA, Šídák multiple comparison post-test) from the respective short-term culture (i.e., relative to
lymphocyte subset and antigen stimulation).
doi:10.1371/journal.pone.0122571.t002
Fig 5. Proliferation of cell subsets in response to mycobacterial antigens. Approximately 7 weeks after
M. bovis challenge, PBMCs from infected cattle were either long or short-term cultured (6 days). Long-term
cells consisted of PBMCs cultured in the presence of rAg85A, rTB10.4, rESAT-6:CFP10 and PPDb for 13
days (n = 4). Subsequently, cells were stained with CellTrace violet dye and re-stimulated with either rESAT-
6:CFP10 or medium in the presence of APCs for an additional six days. Short-term cells consist of CellTrace
Violet-stained PBMC fromM. bovis-infected cattle cultured for six days in the presence of either rESAT-6:
CFP10 or medium (n = 4). Proliferative responses of cells under both culture conditions were compared for
each T cell subset. Data are presented as mean fluorescence intensity (MFI, y-axis) of CellTrace Violet for
analysis of proliferation of T cell subsets (x-axis). Two-way ANOVA, n = 6, Šídák’s multiple comparison post-
test.
doi:10.1371/journal.pone.0122571.g005
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Discussion
This study characterizes Tcm cells in cattle and their participation in the immune response to
M. bovis infection. As early as 6 weeks afterM. bovis infection, CD4+ Tcm cells (CD45RO+,
CCR7+) were detected in long-term, antigen-stimulated PBMC cultures upon recall stimula-
tion with specific (i.e., rESAT-6:CFP-10) or complex (i.e., PPDb) antigens ofM. bovis (Fig 3).
Antigen-specific CD4 cells, as detected by IFN-γ production via either ELISPOT (Fig 1A and
1B) or intracellular cytokine staining (Figs 1C, 2 and 3), within long-term PBMC cultures were
predominately (~76%) Tcm cells (CD45RO+ / CCR7+), with the remainder being Tem cells
Fig 6. Long-term cultured cells have higher proliferative responses than short-term cells. Long-term and short-term cultured PBMCs were analyzed ~
7 weeks after aerosol challenge with virulentM. bovis. Long-term cells consist of PBMC fromM. bovis aerosol infected cattle cultured in the presence of
rAg85A, rTB10.4, rESAT-6:CFP10 and PPDb for 13 days and then CellTrace violet-stained and re-stimulated with either rESAT-6:CFP10, PPDb or medium
in the presence of fresh autologous adherent cells for an additional six days. Short-term cells consist of CellTrace violet-stained PBMC fromM. bovis aerosol
infected cattle cultured for six days in the presence of either rESAT-6:CFP10, PPDb or medium. The gating strategy was performed in accordance with
procedures described in Fig 2A for single cells, and as shown in S3 Fig for lymphocytes, and CD4+ cells. (A) Percentages of CD4+ cells proliferating (low
Celltrace dye MFI) in response to rESAT-6:CFP10 within long or short-term cultures. (B) Percentages of CD4+ cells proliferating (low Celltrace dye MFI) in
response to PPDb within long or short-term cultures. (C)Memory/effector phenotype of proliferating CD4+ cells within long-term or short-term cultures in
response to rESAT-6:CFP10. (D)Memory/effector phenotype of proliferating CD4+ cells within long-term or short-term cultures in response to PPDb. For
panels A and B, cell proliferation differs (**P < 0.01, n = 6 paired Student's t-tests) between long and short-term cultures to either rESAT-6:CFP10 or PPDb.
For panels C and D, Tcm and effector cell content differs (*P < 0.05; **P < 0.01, n = 4 paired Student's t-tests) between short-term and long-term cultures to
either rESAT-6:CFP10 or PPDb.
doi:10.1371/journal.pone.0122571.g006
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(CD45RO+ / CCR7-, ~23%) (Fig 3). Bovine Tcm were highly proliferative as antigen restimula-
tion of cells within long-term cultures induced robust proliferation of CD4+ cells that signifi-
cantly exceeded that of short-term culture cells (Table 2, Figs 5, 6A and S5 Fig). Further
phenotypic analyses of repeat stimulated cultures indicated that a sub-population of bovine
Tcm reverted to effector (both Tem and T effector) phenotypes upon repeat exposure toM.
bovis antigens (Fig 6B). The identification and characterization of CD4 Tcm and Tem subpop-
ulations in cattle should prove useful for development of vaccines and the understanding of the
immunopathogenesis for many infectious diseases of cattle.
Memory cells elicited either by vaccination [30,48] or during pathogen clearance [15,32] are
thought to provide long-term protection due to their prolonged life-span, proliferation poten-
tial, and plasticity [7,33,48]. While events governing immunological memory during chronic
infections (wherein the antigenic stimulation persists) are not well understood, a significant
Tcm response is associated with a favorable outcome for chronic infections, such as HIV and
TB (e.g., latency and self-healing with TB and subclinical disease with HIV) [31,38]. Still, the
relative importance of Tcm for protective immunity against TB is not fully established. Tcm
and ex vivo responses are detected inM. tb-infected patients [33,37] and loss of Tcm responses
(as measured by cultured IFN-γ ELISPOT) is associated with clinical disease progression
[27,37]. Likewise, Tcm responses in the absence of ex vivo IFN-γ production indicate disease
remission, either by self-healing [34,38] or anti-mycobacterial therapy, reinforcing the role that
pathogen clearance has on Tcm function and/or maintenance [34,37]. Intriguingly, in spite of
the presence of Tcm cells, patients receiving curative treatment are still susceptible toM. tb re-
infection [28,31,49]. In the current set of experiments, each of the calves had mild progressive
disease and were responsive to TB antigens in both cultured and ex vivo IFN-γ ELISPOT
assays—similar to what occurs in humans with the mild active form ofM. tb infection [38].
Flow cytometric analysis demonstrated that both Tem and Tcm cells were elicited relatively
early after infection (3 weeks post-infection, Fig 1). It is uncertain if Tcm responses by the ani-
mals would decrease as the disease progresses, but it is frequently reported that animals in late
stages of infection become anergic to measures of cell-mediated immunity, yielding false nega-
tive results upon skin test or ex vivo IFN-γ assays [50–52]. Prolonged infection trials with cattle
are difficult due to biocontainment costs and ethical issues associated with extended duration
of housing large animals within restrictive facilities. Thus, further studies to characterize the
progression of Tcm responses toM. bovis infection in cattle may require sampling of field reac-
tors with various clinical manifestations of the disease including: chronic progressive disease,
M. bovis detected yet no visible lesions (i.e., analogous to latency in humans), and severe
disseminated disease.
Although IFN-γ is key to a successful containment of mycobacterial infections, the interac-
tion between pathogens and host is intricate. Several factors and cytokines may be relevant to
M. bovis infection outcome. Together with IFN-γ, tumor necrosis factor alpha (TNF-α) is cru-
cial for the control of mycobacterial infections of humans and mice [53]. Also, T cells produc-
ing multiple cytokines have been recently identified and may play an important role in
infection outcome. Polyfunctional T cells co-producing IFN-γ, TNF-α and IL-2 are associated
with infection control in HIV, hepatitis C, leishmaniasis and malaria (reviewed in [54,55]).
With TB, conflicting data indicate that polyfunctional T cell responses are associated with ei-
ther clinical disease (i.e., as a biomarker of active TB) or infection control [55]. Polyfunctional
T cells were also recently described in cattle in the response toM. bovis infection [56] and to
anti-mycobacterial vaccines [57]. Studies on polyfunctional responses of bovine memory T
cells under our system (long-term cultured cells) are currently in progress. Additionally, TNF-
α and IL-2 have been evaluated in cattle for diagnostic purposes [58,59].
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UponM. tb infection, the primary immune response may take days to weeks to develop re-
lying on exposure of naive T cells to antigens in secondary lymphoid organs, expansion of anti-
gen-specific cells, and homing of effector cells to the site of infection [60]. With TB, this 2–3
week delay in the response at the primary site of infection seems to be advantageous for the
bacteria, and is observed during infection in cattle, humans, and mice [61]. In theory, the delay
allows the pathogen an opportunity to establish a niche and to direct the ensuing immune re-
sponse in favor of bacterial persistence and chronic immune stimulation. A more rapid homing
of antigen-specific cells to the site of infection (e.g., as may occur in vaccinated animals) might
be advantageous to the host, allowing more effective induction of immune responses (e.g., dif-
ferent activation status, cytokine profile) and circumvention of the pathogens regulation of
host immunity [14,62,63]. These factors may partially explain why Tcm responses elicited by
vaccination appear to be beneficial to the host, while similar Tcm responses are detected in in-
fected animals with progressive disease. The presence of a robust TB-specific Tcm population
elicited by vaccination prior to infection may lead to pathogen clearance before establishment
of immune evasion tactics by the pathogen. Present findings provide a basis for future studies
to determine the relative role of these Tcm and Tem subsets in vaccine-elicited protection.
Lymphocyte homing and trafficking to sites of inflammation and lymphoid organs are me-
diated by the expression of numerous surface adhesion molecules, such as CCR7, CD62L and
CD44. CD62L mediates cell adhesion to peripheral lymph node vascular addressins (e.g., Gly-
CAM-1 and MAdCAM-1) [64]. The expression of CD62L on naïve and memory T cells facili-
tates cell rolling on endothelium in secondary lymphatic organs, contributing to the
compartmentalization of the immune response [64]. CD44 expression on T cells is up regulat-
ed upon activation, thereby promoting movement through the extracellular matrix via interac-
tions with hyaluronic acid and fibronectin [65]. In vitro stimulation of antigen specific T cells
is known to up-regulate CD44 while concurrently down regulating CD62L expression in hu-
mans [66], mice [67] and cattle [56,68]. As in humans [66], bovine T cells expressing CD44
upon ex vivo stimulation frequently co-express CD45RO, while down regulating CD62L
[56,68]. In the present study, CD44 expression on CD4 cells did not differ between Tem and ef-
fector cells under ex vivo or long-term culture conditions (Fig 4B). It is noteworthy that in the
present study the expression of CD62L and CD44 was evaluated only among IFN-γ producing
cells; thus, comparisons between resting/unstimulated versus responding/stimulated cells were
not performed as previously described [68]. Also, the gating strategy employed (based on
CCR7 and CD45RO expression) may also have contributed to the apparently discrepant find-
ings. In the present work, the expression of CD62L was down regulated in effector cells, inter-
mediate on Tem cells, and high on Tcm cells (Fig 4A). Although Tcm cells highly expressed
CD62L, these cells maintained high CD44 expression. The relevance of the level of CD44 ex-
pression by memory T cells is controversial for both mice [15,69,70] and humans [66,69]. Al-
though few authors investigated T cell memory responses in cattle [24,26,41,71–73], to our
knowledge no other description of the expression of CD44 by bovine Tcm cells (as defined by
CCR7 and CD45RO expression) has been published, making direct comparisons not possible.
However, data from mice suggest that although the expression of CD44 is dispensable for early
expansion, trafficking and cytokine production of Th1 cells; expression of CD44 is required for
long-term cell survival and anamnestic responses to re-infection [70]. In humans and mice it is
long known that, together with CD62L, CCR7 plays a major role for cell homing to secondary
lymphoid organs (SLO). For cattle, CCR7 expression is required for CD4 T cell migration to
SLO, while homing of γδ T cells to SLO is not mediated by CCR7 expression [74]. To our
knowledge further cytometric analysis of CCR7 positive cells into Tcm and naïve subsets, as
well the antigen specific memory response to infection has not been done in cattle. Totté et al.
[73] reported a subset of CD4 cells with Tcm characteristics afterMycoplasma mycoides
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infection and pathogen clearance. Upon restimulation, cells expressing CD62L were highly
proliferative, while being less prone to down regulate CCR7 transcription. Conversely, cells
lacking CD62L showed greater IFN-γ production, lower proliferation and down regulation of
CCR7 transcription. Our findings indicate that in response to antigenic stimulation, Tcm cells
strongly proliferated (Figs 5 and 6A) and were capable of switching to Tem and effector cells
(CCR7 down regulation—Fig 6B).
We also analyzed the contribution of γδ, CD8 and CD8-expressing γδ T cells to the prolifer-
ative response of long- and short-term cultures. In cattle, CD8+ T-cells can bear either α/β or
γ/δ TCR, with profound impacts on antigen specificity and immunological memory, as classi-
cal antigen-specific immunological memory resides in α/β T-cells [75,76]. In BCG vaccinated
animals, CD8 memory responses were elicited within the CD8 α/β TCR expressing cells, but
not the CD8 expressing γδ T cells [76]. In the present study, γδ CD8+ T cells showed greater
proliferation under short-term culture conditions, while the proliferative response of γδ+ CD8+
T cells did not differ based on culture length (i.e., short- vs long-term). However, γδ+ CD8+ T
cells constituted only a small population under both culture conditions (Table 1).
In summary, the present study demonstrates Tcm cells in the response to experimentalM.
bovis challenge. Our findings suggest that upon repeat in vitro stimulation Tcm cells proliferate
into different effector cell types. The association of Tcm cells with vaccine-elicited protection,
as well as in infection outcome, is still to be determined.
Supporting Information
S1 Fig. Cattle infected with eitherM. bovis 95–1315 orM. bovis 10–7428 have similar long-
term cultured and ex vivo IFN-γ responses afterM. bovis aerosol challenge. Cultured ELI-
SPOT analysis was performed ~3 weeks after challenge with virulentM. bovis. Long-term cul-
tured cells were generated by stimulating PBMC with a cocktail of rAg85A (1 μg/ml), rTB10.4
(1 μg/ml), and rESAT-6:CFP10 (1 μg/ml) antigens as well as PPDb (5 μg/ml) for 13 days fol-
lowed by transfer to ELISPOT plates with APCs and addition of either rESAT-6:CFP10, PPDb
or medium alone. For the ex vivo response freshly isolated PBMCs were stimulated with
rESAT-6:CFP10, PPDb or medium alone for 16h. Medium control responses were subtracted
from antigen-stimulated responses and results are presented as mean spot forming cells (SFC)/
million cells (± SEM, n = 8) for (A) long-term culture or (B) ex vivo conditions. Responses did
not differ betweenM. bovis 95–1315 andM. bovis 10–7428 infection groups (Two-way
ANOVA, followed by Tukey’s multiple comparison).
(TIF)
S2 Fig. Evaluation of IFN-γ responses toM. avium-derived PPD (PPDa) andM. bovis-de-
rived PPD (PPDb) before challenge. Responses to PPDa and PPDb prior to challenge were
examined using a commercial IFN-γ release assay (i.e., Bovigam, Prionics Ag, Schlieren, Swit-
zerland) according to manufacturer instructions. Briefly, duplicate 250l heparinised whole
blood aliquots were distributed in 96-well plates with PPDb (10g/ml, Prionics Ag), PPDa
(10g/ml, Prionics Ag), or no antigen and incubated at 39°C/5% CO2 for 20 hours. IFN-γ con-
centrations in stimulated plasma were determined using a commercial ELISA-based kit (Bovi-
gam, Prionics Ag). Absorbencies of standards (recombinant bovine IFN-γ; Endogen, Rockford,
IL) and test samples were read at 450 nm using an ELISA plate reader (Molecular Devices,
Menlo Park, CA). Duplicate samples for individual treatments were analyzed and data pre-
sented as optical densities at 450 nm of the response to PPDb or PPDa minus the response to
no-antigen (mean ± SEM). Response to PPDa exceeded (P< 0.05, n = 24, paired Student's t-
test) the response to PPDb.
(TIF)
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S3 Fig. Cell function and expression of cell markers on different human T cell memory sub-
sets. (A) Identification of memory subsets in the human peripheral blood based on the expres-
sion of CD45R0, CCR7, CD62L. (B) The differentiation of T cells occurs simultaneously with
changes in cell functions. Adapted from Mahnkea et al. [46]
(TIF)
S4 Fig. Effector/memory phenotype of cells producing IFN-γ in response to PPDb under
long-term and ex vivo conditions by infection group (A) and the respective efector/memory
distribution of total CD4 cells, both IFN-γ+ positive and IFN-γ- (B). Peripheral blood mono-
nuclear cells were isolated from calves ~ 8 weeks after challenge with virulentM. bovis (n = 8).
Cells were stimulated with a cocktail of rAg85A (1 μg/ml), rTB10.4 (1 μg/ml), and rESAT-6:
CFP10 (1 μg/ml) as well as PPDb (5 μg/ml) for 13 days followed by transfer to 96 well round
bottom plates with APCs and addition of media alone, PPDb or rESAT-6:CFP10 for an addi-
tional 16h. For ex vivo culture, PBMC were stimulated with media alone, PPDb or rESAT-6:
CFP10 for 16h. (A) Relative contribution of Tcm, Tem, and T effector cells to IFN-γ produc-
tion in response to PPDb by long-term (i.e., 14-day) (left) and ex vivo (i.e., 16 h) (right) cultures
did not differ betweenM. bovis 95–1315 (solid) orM. bovis 10–7428 (dashed) infection groups
for any of the phenotypes (Two-way ANOVA, Šídák’s multiple comparison post-test). (B) Rel-
ative distribution of Tcm, Tem and T effector CD4+ cells in response to PPDb. (mean ± SEM,
P< 0.05, P< 0.01; n = 8, Two-way ANOVA, Šídák’s multiple comparison post-test).
(TIF)
S5 Fig. Representative cytometric plots of the long-term and short-term cultured prolifer-
ative responses to mycobacterial antigens by CD4, CD8 and γδ T cells. Long-term and
short-term cultured PBMCs were analyzed ~ 7 weeks after aerosol challenge with virulentM.
bovis. Long-term cells consist of PBMC fromM. bovis infected cattle cultured in the presence
of rAg85A, rTB10.4, rESAT-6:CFP10 and PPDb for 13 days and then CellTrace violet-stained
and re-stimulated with either rESAT-6:CFP10, PPDb or medium in the presence of fresh autol-
ogous adherent cells for an additional six days. Short-term cells consist of CellTrace violet-
stained PBMC fromM. bovis infected cattle cultured for six days in the presence of rESAT-6:
CFP10, PPDb or medium.
(TIF)
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